Correlation Between Inhibikase Therapeutics and DiaMedica Therapeutics
Can any of the company-specific risk be diversified away by investing in both Inhibikase Therapeutics and DiaMedica Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibikase Therapeutics and DiaMedica Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibikase Therapeutics and DiaMedica Therapeutics, you can compare the effects of market volatilities on Inhibikase Therapeutics and DiaMedica Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibikase Therapeutics with a short position of DiaMedica Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibikase Therapeutics and DiaMedica Therapeutics.
Diversification Opportunities for Inhibikase Therapeutics and DiaMedica Therapeutics
0.67 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Inhibikase and DiaMedica is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Inhibikase Therapeutics and DiaMedica Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DiaMedica Therapeutics and Inhibikase Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibikase Therapeutics are associated (or correlated) with DiaMedica Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DiaMedica Therapeutics has no effect on the direction of Inhibikase Therapeutics i.e., Inhibikase Therapeutics and DiaMedica Therapeutics go up and down completely randomly.
Pair Corralation between Inhibikase Therapeutics and DiaMedica Therapeutics
Considering the 90-day investment horizon Inhibikase Therapeutics is expected to under-perform the DiaMedica Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Inhibikase Therapeutics is 2.31 times less risky than DiaMedica Therapeutics. The stock trades about -0.18 of its potential returns per unit of risk. The DiaMedica Therapeutics is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest 487.00 in DiaMedica Therapeutics on October 20, 2024 and sell it today you would earn a total of 84.00 from holding DiaMedica Therapeutics or generate 17.25% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inhibikase Therapeutics vs. DiaMedica Therapeutics
Performance |
| Timeline |
| Inhibikase Therapeutics |
| DiaMedica Therapeutics |
Inhibikase Therapeutics and DiaMedica Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibikase Therapeutics and DiaMedica Therapeutics
The main advantage of trading using opposite Inhibikase Therapeutics and DiaMedica Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibikase Therapeutics position performs unexpectedly, DiaMedica Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DiaMedica Therapeutics will offset losses from the drop in DiaMedica Therapeutics' long position.| Inhibikase Therapeutics vs. DiaMedica Therapeutics | Inhibikase Therapeutics vs. Milestone Pharmaceuticals | Inhibikase Therapeutics vs. Seres Therapeutics | Inhibikase Therapeutics vs. Oncolytics Biotech |
| DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |